Lab grown diamond jewellery brand Limelight Diamonds has raised Rs 275 crore in a strategic funding round led by the company's core promoters, the Bhathwari Group, along with participation from key strategic partners from the jewellery industry. The capital was raised through a combination of equity and cash consideration and will be utilised to strengthen the company's vertical integration capabilities, expand manufacturing infrastructure, enhance design and innovation capabilities, and accelerate retail expansion across India, Limelight Diamonds said in a press release. Founded in 2019 by Pooja Madhavan, Limelight Diamonds is a lab grown diamond jewellery brand specialising in pure CVD lab grown diamonds. The brand offers consumers jewellery with exceptional brilliance, purity, and contemporary design. Over the past few years, the brand says it has witnessed rapid nationwide expansion and now boasts the widest retail footprint for lab grown diamond jewellery in India, with over 75 exclusive brand outlets across more than 45 cities. Its collections span solitaires, everyday fine jewellery, and statement pieces, catering to modern Indian consumers. Limelight Diamonds plans to expand its retail presence across metro cities, Tier I cities, and emerging Tier II markets. The company aims to significantly increase its national retail footprint through a combination of company owned and franchise operated stores, with a target of adding 100 stores in 2026 and scaling up to 200 stores by 2027. According to Limelight Diamonds, lab grown diamonds represent a modern, technology led manufacturing opportunity for India. With strong domestic manufacturing capabilities, skilled craftsmanship, and growing consumer demand, the category aligns closely with India's ambition to emerge as a global manufacturing and export hub. Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investorshere.
